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Peter C. Block, MDSEE PAGE 450T here are lots of reasons to be cautiousabout doing a transseptal puncture. Visionsof tamponade, vagal reactions, aortic entry,
and speciﬁc placement of the puncture for thera-
peutic interventions quickly come to mind. To be
honest, once the transseptal puncture is safely
done, I always feel a bit better. But now, with large
bore catheters used for therapeutic transcatheter
procedures, transseptal punctures are more than
that—they all become atrial septal tears. We produce
iatrogenic atrial septal defects (iASD) while (hope-
fully) improving another abnormality. We learned
that with balloon mitral valvotomy almost 30 years
ago. Fortunately, the atrial septum seems to be rela-
tively forgiving as far as “enlargement” of the punc-
ture to accommodate large guiding catheters is
concerned. If complications occur, they are mostly
related to the initial puncture, not to the placement
of larger catheters. What has been a bit mysterious
is what happens after the procedure. In early studies,
about 1 in 5 patients developed left-to-right shunts
after balloon mitral valvotomy, and, of those, more
than one-half had apparently “closed” or “healed”
the defect just shy of 1 year (1). Even with smaller
catheters, the initial 20% iASD rate occurs (2). It is
likely that the incidence of iASD is actually higher
because ﬁnding a post-procedure iASD is related to
the test used for detection (3). Regardless, it seems
clear that crossing the atrial septum for transcatheter
interventions leaves an iASD that can result in
left-to-right or, in some cases, right-to-left shunting.
So here is the conundrum: does the iASD matter?
Theoretically, for patients with right atrial hyper-
tension from any cause (right ventricular failure,*Editorials published in JACC: Cardiovascular Interventions reﬂect the
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cyanosis are real threats. For patients with left-
to-right shunts, right heart enlargement, atrial
arrhythmias, right ventricular failure, and increases
in pulmonary artery pressure can result.In this issue of JACC: Cardiovascular Interventions,
Schueler et al. (4) shed further light on this conun-
drum. They report on persistence of iASD after
MitraClip (Abbott Vascular, Santa Clara, California)
procedures for patients with functional mitral regur-
gitation (MR), the latest large-catheter transseptal
intervention in the structural armamentarium. Their
evaluation of patient characteristics in an attempt to
predict which patients are most vulnerable to iASD
produces a number of important teaching points.
1) One-half of their patients had iASD by trans-
esophageal echocardiography in follow-up. 2) No
predictive demographic differences could be found
among patients with and without iASD, nor were
there differences in acute procedural success, mitral
gradient, or residual MR. 3) MitraClip procedures
were longer in patients with iASD, suggesting that
more manipulation and longer “dwell-times” of the
21-F transseptal sheath make a difference. Their
report also indicates that the presence of an iASD
seems to make a difference in outcomes and even
mortality after transcatheter mitral repair. Those with
iASD had less improvement in walking distances,
higher N-terminal pro–B-type natriuretic peptide, and
worse New York Heart Association class at 6-month
follow-up. Making any “hard” statements about
mortality is ﬂawed because of the small numbers in
their study. But, though small numbers cloud the
statistics, almost 20% of iASD patients died within
6 months, compared with only 3% in the non-iASD
group. All belonged to a vulnerable population to
begin with. They had high New York Heart Asso-
ciation class, no operative option, and functional
MR 2þ or more. Nonetheless, most of their patients
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461improved after the procedure. So what is it that
makes those with iASD possibly fare less well?
Perhaps the answer lies in the follow-up echo-
cardiographic data in the Schueler et al. (4) report.
Mysteriously, only patients without iASD had
reductions in both left ventricular end-systolic and
end-diastolic volumes without changes in ejection
fraction. The iASD patients had no change in left
ventricular end-diastolic volumes, suggesting some
left ventricular abnormality in iASD patients. Less
mysteriously, estimated pulmonary artery pressures
(PAP) were also different. In the overall cohort, PAP
was reduced after the procedure. However, PAP in the
iASD patients was not reduced, whereas in patients
without iASD there was a signiﬁcant reduction. Could
persistence of pulmonary hypertension in patients
with left-to-right shunting be responsible for lack
of functional improvement and possibly even an
increase in mortality at 6 months? That question thenraises another: should an iASD be closed after the
procedure to reduce right-sided volumes and hope-
fully PAP? Both questions are hypothesis generating
and will demand further evaluation and clinical
reports. But for practical, clinical purposes, the
Schueler et al. (4) data suggest that if PAP does not
decrease after a successful MitraClip procedure in
patients with functional MR, they may be heading for
a worse outcome. Transient balloon occlusion of the
iASD during a right heart catheterization in follow-up
with simultaneous measurement of PAP would be
enlightening. If PAP decreases with balloon occlu-
sion, it might identify those patients who would
beneﬁt from iASD closure. That is an intriguing issue.
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